Optimal therapeutic anticoagulation

Area of Science:

• Cardiology
• Hematology
• Vascular Medicine

Background:

• Thrombosis prevention requires tailored anticoagulation intensity.
• Different patient groups and thrombosis types necessitate varying treatment approaches.

Purpose of the Study:

• To review literature on optimal anticoagulation intensity for preventing thrombus development and growth.
• To guide clinical decisions regarding anticoagulation strategies for diverse thrombotic risks.

Main Methods:

• Literature review of studies on anticoagulation therapy for thrombosis prevention.
• Analysis of efficacy and bleeding risks associated with different anticoagulation intensities and regimens.

Main Results:

• Elective surgery prophylaxis is achieved with low-risk heparin or coumarin.
• Post-traumatic prophylaxis and active venous thrombosis management require more intensive anticoagulation.
• High-intensity anticoagulation (target INR 4) reduces systemic emboli by 90% in high-risk patients.
• Arterial thrombosis prevention is limited by increased bleeding risk above INR 5.
• Target INR of 3.5 in older patients reduces reinfarction by two-thirds.

Conclusions:

• Anticoagulation intensity must be carefully balanced against bleeding risk.
• Current antiplatelet therapies show limited success in thrombosis prevention and treatment.
• Tailored anticoagulation strategies are crucial for effective thrombosis management across different clinical scenarios.